3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Gastrointestinal Stromal Tumors
4
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Melanoma
1
Digestive System Neoplasms
1
Congenital Bone Marrow Failure Syndromes
1
Burkitt Lymphoma
1
Blast Crisis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rare Malignant Neoplasm
×
Imatinib Mesylate
×
30 days
×
Clear all
No trials found.